MAPT and Alzheimer disease: This study by Mulet et al. characterizes oral microbiome–derived proteins in brain extracellular vesicles from post-mortem samples of individuals with Alzheimer's disease and vascular dementia, revealing stage-specific alterations and molecular interactions with amyloid and tau pathology.